ITRAQ-Based Proteomics Identification of Serum Biomarkers of Two Chronic Hepatitis B Subtypes Diagnosed by Traditional Chinese Medicine

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2016 Dec 28

PMID 28025641

Citations 9

Authors

Jiankun Yang

Lichao Yang

Baixue Li

Weilong Zhou

Sen Zhong

Zhenhua Zhuang

Bin Yang

Maoshan Chen

Quansheng Feng

Affiliations

Soon will be listed here.

Abstract

Chronic infection with hepatitis B virus (HBV) is a leading cause of cirrhosis and hepatocellular carcinoma. By traditional Chinese medicine (TCM) pattern classification, damp heat stasis in the middle-jiao (DHSM) and liver Qi stagnation and spleen deficiency (LSSD) are two most common subtypes of CHB. In this study, we employed iTRAQ proteomics technology to identify potential serum protein biomarkers in 30 LSSD-CHB and 30 DHSM-CHB patients. Of the total 842 detected proteins, 273 and 345 were differentially expressed in LSSD-CHB and DHSM-CHB patients compared to healthy controls, respectively. LSSD-CHB and DHSM-CHB shared 142 upregulated and 84 downregulated proteins, of which several proteins have been reported to be candidate biomarkers, including immunoglobulin (Ig) related proteins, complement components, apolipoproteins, heat shock proteins, insulin-like growth factor binding protein, and alpha-2-macroglobulin. In addition, we identified that proteins might be potential biomarkers to distinguish LSSD-CHB from DHSM-CHB, such as A0A0A0MS51_HUMAN (gelsolin), PON3_HUMAN, Q96K68_HUMAN, and TRPM8_HUMAN that were differentially expressed exclusively in LSSD-CHB patients and A0A087WT59_HUMAN (transthyretin), ITIH1_HUMAN, TSP1_HUMAN, CO5_HUMAN, and ALBU_HUMAN that were differentially expressed specifically in DHSM-CHB patients. This is the first time to report serum proteins in CHB subtype patients. Our findings provide potential biomarkers can be used for LSSD-CHB and DHSM-CHB.

Citing Articles

Proteomic investigation and biomarker identification of lung and spleen deficiency syndrome in HIV/AIDS immunological nonresponders.

Wang Y, Ji S, Xia X, Wan T, Zou J, Li B J Thorac Dis. 2023; 15(3):1460-1472.

PMID: 37065569 PMC: 10089843. DOI: 10.21037/jtd-23-322.

An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19.

Wang J, Zhang W, Roehrl V, Roehrl M, Roehrl M Front Immunol. 2022; 13:831849.

PMID: 35401574 PMC: 8987778. DOI: 10.3389/fimmu.2022.831849.

Circular RNA, microRNA and Protein Profiles of the Longissimus Dorsi of Germany ZIKA and Sichuan White Rabbits.

Zhang X, Zhang C, Yang C, Kuang L, Zheng J, Tang L Front Genet. 2022; 12:777232.

PMID: 35003217 PMC: 8740122. DOI: 10.3389/fgene.2021.777232.

An Autoantigen Atlas from Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19.

Wang J, Zhang W, Roehrl M, Roehrl V, Roehrl M bioRxiv. 2021; .

PMID: 33501444 PMC: 7836114. DOI: 10.1101/2021.01.24.427965.

Chronic hepatitis B: dynamic change in Traditional Chinese Medicine syndrome by dynamic network biomarkers.

Lu Y, Fang Z, Zeng T, Li M, Chen Q, Zhang H Chin Med. 2019; 14:52.

PMID: 31768187 PMC: 6873721. DOI: 10.1186/s13020-019-0275-4.

References

Wiese S, Reidegeld K, Meyer H, Warscheid B . Protein labeling by iTRAQ: a new tool for quantitative mass spectrometry in proteome research. Proteomics. 2006; 7(3):340-50. DOI: 10.1002/pmic.200600422. View

Smith M, Yue Z, Korth M, Do H, Boix L, Fausto N . Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers. Hepatology. 2003; 38(6):1458-67. DOI: 10.1016/j.hep.2003.09.024. View

Zhang T, Xie N, He W, Liu R, Lei Y, Chen Y . An integrated proteomics and bioinformatics analyses of hepatitis B virus X interacting proteins and identification of a novel interactor apoA-I. J Proteomics. 2013; 84:92-105. DOI: 10.1016/j.jprot.2013.03.028. View

Wang H, Gao Y, Jin X, Xiao J . Expression of contactin associated protein-like 2 in a subset of hepatic progenitor cell compartment identified by gene expression profiling in hepatitis B virus-positive cirrhosis. Liver Int. 2009; 30(1):126-38. DOI: 10.1111/j.1478-3231.2009.02151.x. View

Huang C, Chen Y, Ting L . Hepatitis B virus core protein interacts with the C-terminal region of actin-binding protein. J Biomed Sci. 2000; 7(2):160-8. DOI: 10.1007/BF02256623. View

Kant J, Lord S, Crabtree G . Partial mRNA sequences for human A alpha, B beta, and gamma fibrinogen chains: evolutionary and functional implications. Proc Natl Acad Sci U S A. 1983; 80(13):3953-7. PMC: 394177. DOI: 10.1073/pnas.80.13.3953. View

Garcia-Heredia A, Marsillach J, Aragones G, Guardiola M, Rull A, Beltran-Debon R . Serum paraoxonase-3 concentration is associated with the severity of hepatic impairment in patients with chronic liver disease. Clin Biochem. 2011; 44(16):1320-4. DOI: 10.1016/j.clinbiochem.2011.08.003. View

Suhler E, Lin W, Yin H, Lee W . Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis. Crit Care Med. 1997; 25(4):594-8. DOI: 10.1097/00003246-199704000-00007. View

Robinson M, McCarthy D, Smyth G . edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009; 26(1):139-40. PMC: 2796818. DOI: 10.1093/bioinformatics/btp616. View

10.

Cheung K, Libbrecht L, Tilleman K, Deforce D, Colle I, Van Vlierberghe H . Galectin-3-binding protein: a serological and histological assessment in accordance with hepatitis C-related liver fibrosis. Eur J Gastroenterol Hepatol. 2010; 22(9):1066-73. DOI: 10.1097/MEG.0b013e328337d602. View

11.

Lim S, Park S, Yoo J, Park Y, Kim H, Jang K . Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules. World J Gastroenterol. 2005; 11(14):2072-9. PMC: 4305774. DOI: 10.3748/wjg.v11.i14.2072. View

12.

Chang K, Jiang J, Cai Z, Luo G . Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture. J Virol. 2007; 81(24):13783-93. PMC: 2168882. DOI: 10.1128/JVI.01091-07. View

13.

Lin W, Jiao B, Wu Y, Chen W, Lin X . Hepatitis B virus X protein blocks filamentous actin bundles by interaction with eukaryotic translation elongat ion factor 1 alpha 1. J Med Virol. 2012; 84(6):871-7. DOI: 10.1002/jmv.23283. View

14.

Agrawal S, Dhiman R, Limdi J . Evaluation of abnormal liver function tests. Postgrad Med J. 2016; 92(1086):223-34. DOI: 10.1136/postgradmedj-2015-133715. View

15.

Goldstein S, Zhou F, Hadler S, Bell B, Mast E, Margolis H . A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol. 2005; 34(6):1329-39. DOI: 10.1093/ije/dyi206. View

16.

Wong D, Purcell R, Sreenivasan M, Prasad S, Pavri K . Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet. 1980; 2(8200):876-9. DOI: 10.1016/s0140-6736(80)92045-0. View

17.

Hueging K, Weller R, Doepke M, Vieyres G, Todt D, Wolk B . Several Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released Viruses. PLoS One. 2015; 10(7):e0134529. PMC: 4520612. DOI: 10.1371/journal.pone.0134529. View

18.

Ng R, Lau C, Lee S, Tsui S, Fung K, Waye M . cDNA microarray analysis of early gene expression profiles associated with hepatitis B virus X protein-mediated hepatocarcinogenesis. Biochem Biophys Res Commun. 2004; 322(3):827-35. DOI: 10.1016/j.bbrc.2004.07.188. View

19.

Yuan W, Huang T, Yu J, Zeng L, Lian B, He Q . Comparative analysis of viral protein interaction networks in Hepatitis B virus and Hepatitis C virus infected HCC. Biochim Biophys Acta. 2013; 1844(1 Pt B):271-9. DOI: 10.1016/j.bbapap.2013.06.002. View

20.

Kuramitsu Y, Takashima M, Yokoyama Y, Iizuka N, Tamesa T, Akada J . Up-regulation of 42 kDa tubulin alpha-6 chain fragment in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus. Anticancer Res. 2011; 31(10):3331-6. View